Balakrishnan Shankar
Direttore operativo presso Canary Medical, Inc.
Provenienza dei contatti di primo grado di Balakrishnan Shankar
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
Public Company | Medical Specialties | 9 | |
Canary Medical, Inc.
Canary Medical, Inc. Electronic Equipment/InstrumentsElectronic Technology Canary Medical, Inc. develops medical devices to collect medical data. The company was founded by William L. Hunter and is headquartered in Vancouver, Canada.
6
| Holding Company | Electronic Equipment/Instruments | 6 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Balakrishnan Shankar tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
ARCELLX, INC. | Biotechnology | Director/Board Member Director/Board Member Corporate Officer/Principal | |
Summatix Pty Ltd.
Summatix Pty Ltd. Internet Software/ServicesTechnology Services Summatix Pty Ltd. operates as a medical data monetization platform. The firm provides connectivity to its HIPAA compliant platform, software, APIs, and data management. The company is headquartered in Melbourne, Australia. | Internet Software/Services | Director/Board Member Director/Board Member | |
CVRX, INC. | Medical Specialties | Director/Board Member Director/Board Member | |
HTG MOLECULAR DIAGNOSTICS, INC. | Miscellaneous Commercial Services | Chairman Director/Board Member | |
Thesan Pharmaceuticals, Inc.
Thesan Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Thesan Pharmaceuticals, Inc. provides novel therapeutics for disorders of the skin. The company focuses on the discovery and development of new chemical entities that provide improved treatment options to patients. Thesan Pharmaceuticals was founded in 2011 by Edward P. Monaghan and is headquartered in Carlsbad, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
OTONOMY | Biotechnology | Chairman Director/Board Member | |
Bioscience Managers Pty Ltd.
Bioscience Managers Pty Ltd. Investment ManagersFinance BioScience Managers Pty Ltd (Bioscience Managers) is a private equity & venture capital firm founded in 2003 by Jeremy Curnock Cook. The firm is headquartered in Melbourne, Australia. | Investment Managers | Consultant / Advisor Private Equity Investor | |
University of California, Berkeley | College/University | Graduate Degree Graduate Degree | |
NKARTA, INC. | Biotechnology | Director/Board Member Chairman | |
Ray Therapeutics, Inc.
Ray Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Ray Therapeutics, Inc. is an American company that is developing a lead candidate, RTX-015, to treat retinitis pigmentosa, a degenerative retinal disease. Ray Therapeutics is based in an undisclosed location. The company's mission is to restore vision for people with retinal degeneration using optogenetics gene therapies. Ray Therapeutics is pursuing multiple drug development programs for a range of degenerative retinal diseases, focusing on preserving and restoring vision in patients using the ground-breaking science of optogenetics. The company was founded by Paul Bresge and Sean Ainsworth, with Paul Bresge serving as CEO since incorporation. | Miscellaneous Commercial Services | Director/Board Member | |
FirstLight Bio, Inc. | Director/Board Member | ||
New Enterprise Associates LLC
New Enterprise Associates LLC Investment ManagersFinance New Enterprise Associates LLC is an alternative investment manager. The private company is based in Timonium, MD. The company was founded in 1978 by Chuck Newhall, C. Richard Kramlich. | Investment Managers | Corporate Officer/Principal | |
BLACK DIAMOND THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Korro Bio, Inc.
Korro Bio, Inc. BiotechnologyHealth Technology Korro Bio, Inc. engages in the development of a bio therapeutics. It focuses on a proprietary platform designed to selectively edit messenger RNA and recode specific codons to effect changes in protein structure and function across multiple tissues. The company was founded by Jean-Fran?ois Formela, Josh Rosenthal, Nessan Bermingham, and Andrew Fraley in 2018 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
SpyGlass Pharma Inc
SpyGlass Pharma Inc Miscellaneous Commercial ServicesCommercial Services Spyglass Ophthalmics, Inc. develops products for vision and eye care. The company was founded by Malik Y. Kahook and Glenn Sussman and is headquartered in Mission Viejo, CA. | Miscellaneous Commercial Services | Director/Board Member | |
MONTE ROSA THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Stablix, Inc.
Stablix, Inc. Miscellaneous Commercial ServicesCommercial Services Stablix, Inc. is a biotechnology company based in New York, NY. The company is focused on establishing a new paradigm for tackling diverse diseases by harnessing the power of the body's own cellular machinery through targeted protein stabilization. Stablix's restored™ platform generates heterobifunctional small molecules (restoracs™) that selectively recruit active deubiquitinases (dubs) to target proteins for precise removal of ubiquitin to restore protein function. The company is currently advancing its lead programs towards clinical studies. The company's platform is based on the work of Henry Colecraft, Ph.D., professor of physiology and cellular biophysics, and professor of pharmacology, Columbia University Irving Medical Center. Stablix was founded in June 2021 with a $63 million series A led by founding investor Versant Ventures with New Enterprise Associates (NEA), Cormorant Asset Management, Euclidean Capital, and Alexandria Venture Investments. Stuart Anthony Kingsley has been the CEO of the company since 2022. | Miscellaneous Commercial Services | Director/Board Member | |
Tune Therapeutics, Inc.
Tune Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Tune Therapeutics, Inc. is a genetic medicine company based in Durham, NC. Tune Therapeutics is pioneering a new therapeutic modality with its versatile and powerful tempo epigenomic control platform. The platform has the potential to fine-tune any gene network and unlock the full power and potential of regenerative medicine. The company is driving through an inflection point in the history of genetic medicine by addressing thousands of common and complex diseases for which no curative treatment is available. Tune Therapeutics pioneers next-generation genetic therapies by exploring epigenomic control for discovering novel targets that are inaccessible to other approaches. The company was founded in 2020 by Fyodor Urnov, Akira Matsuno, Charles A. Gersbach. The CEO is Matt Kane. | Pharmaceuticals: Major | Director/Board Member | |
University of Pennsylvania Medical Center | College/University | Doctorate Degree | |
858 Therapeutics, Inc.
858 Therapeutics, Inc. BiotechnologyHealth Technology 858 Therapeutics, Inc. operates as a pharmaceutical company. The company was founded in 2019 and is headquartered in San Diego, CA. | Biotechnology | Director/Board Member | |
Launchpad Therapeutics, Inc.
Launchpad Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Launchpad Therapeutics, Inc. develops novel therapeutics. | Miscellaneous Commercial Services | Director/Board Member | |
OYSR POIN | Pharmaceuticals: Major | Chairman | |
Nexo Therapeutics, Inc.
Nexo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Nexo Therapeutics is a small molecule oncology company that focuses on discovering and developing new drugs for cancer patients who do not have effective treatments. The company is based in Littleton, CO and Watertown, MA. The company uses covalent ligand discovery, chemical biology, cancer biology, and medicinal chemistry to target the underlying causes of cancer through innovative methods. Nexo Therapeutics was founded by John Athanosopoulos, Andrew J. Phillips, Michael Kim, and Rhamy Zeid. Andrew J. Phillips has been the CEO of the company since 2022. | Pharmaceuticals: Major | Director/Board Member | |
TrialStat Corp.
TrialStat Corp. Miscellaneous Commercial ServicesCommercial Services TrialStat Corp. provides clinical data solutions for life science products. It offers customer suport, CROFirst, user training and data center services. The firm serves pharmaceutical, biotechnology and contract research organizations. The company was founded by Peter O'Blenis in 2001 and is headquartered in Ottawa, Canada. | Miscellaneous Commercial Services | Founder | |
Privacy Analytics, Inc.
Privacy Analytics, Inc. Packaged SoftwareTechnology Services Privacy Analytics, Inc. provides data anonymization software solutions for healthcare organizations, insurance and medical claims providers, and medical device manufacturers to safeguard and enable data for secondary purpose. The company was founded by Khaled El Emam in 2007 and is headquartered in Ottawa, Canada. | Packaged Software | Founder | |
Childrens Hospital of Eastern Ontario Research Institute, Inc.
Childrens Hospital of Eastern Ontario Research Institute, Inc. Hospital/Nursing ManagementHealth Services Childrens Hospital of Eastern Ontario Research Institute, Inc. operates a pediatric health and research center. Its services include early childhood program, lifespan program, assistive technology program, special activities and playgroups, and respite services. The company was founded on May 17, 1974 and is headquartered in Ottawa, Canada. | Hospital/Nursing Management | Chief Tech/Sci/R&D Officer | |
Electronic Health Information Laboratory
Electronic Health Information Laboratory Miscellaneous Commercial ServicesCommercial Services Electronic Health Information Laboratory engages in research program specializing in sharing of electronic health information. It offers theoretical work, empirical work, and knowledge translation. The company was founded in 2005 and is headquartered in Ottawa, Canada. | Miscellaneous Commercial Services | Director/Board Member | |
National Research Council of Canada
National Research Council of Canada Miscellaneous Commercial ServicesCommercial Services National Research Council of Canada, provides research & development. It services include research programs and collaboration opportunities, technical and advisory services, licensing opportunities and industrial research assistance program. The company was founded by Graham W. Burton and is headquartered in Ottawa, ON. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
Fraunhofer-Institut für Solare Energiesysteme ISE
Fraunhofer-Institut für Solare Energiesysteme ISE Miscellaneous Commercial ServicesCommercial Services Part of Fraunhofer-Gesellschaft eV, Fraunhofer-Institut für Solare Energiesysteme ISE is a research institute based in Freiburg, Germany. The German company conducts research for energy sustainability purposes. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
King's College London | College/University | Doctorate Degree | |
Morgan Stanley Venture Partners
Morgan Stanley Venture Partners Investment ManagersFinance Morgan Stanley Venture Partners (MSVP) is a venture capital firm subsidiary of Morgan Stanley Investment Management Merchant Banking, which is ultimately owned by Morgan Stanley (NYSE: MWD) founded in 1986.The firm is headquartered in New York. | Investment Managers | Private Equity Analyst | |
GENOCEA BIOSCIENCES, INC. | Biotechnology | Director/Board Member | |
MBX Biosciences, Inc.
MBX Biosciences, Inc. Electronic Equipment/InstrumentsElectronic Technology MBX Biosciences, Inc. operates as a preclinical-stage biotech company. It creates therapies to treat rare endocrine diseases. The company was founded by Peter Kent Hawryluk and Timothy Knickerbocker and is headquartered in Carmel, IN. | Electronic Equipment/Instruments | Director/Board Member | |
Solace Therapeutics, Inc.
Solace Therapeutics, Inc. Medical SpecialtiesHealth Technology Solace Therapeutics, Inc. develops non-surgical treatments for common bladder disorders. It offers medical devices for stress urinary incontinence, overactive bladder, male voiding dysfunction, and lower urinary tract symptoms. The company was founded by Kevin G. Connors in 2002 and is headquartered in Framingham, MA. | Medical Specialties | Director/Board Member | |
Rainier Therapeutics, Inc.
Rainier Therapeutics, Inc. BiotechnologyHealth Technology Rainier Therapeutics, Inc. operates as a biotechnology company that develops a targeted biologic for the potential treatment of metastatic bladder cancer. It provides Vofatamab, an antibody that is focused on the fibroblast growth factor of bladder and other cancer. The company was founded by Stephen Lau and is headquartered in San Leandro, CA. | Biotechnology | Director/Board Member | |
NEA Management Co. LLC
NEA Management Co. LLC Investment ManagersFinance New Enterprise Associates LLC (New Enterprise Associates) is a venture capital firm founded in 1977. The firm headquartered in Menlo Park, California. | Investment Managers | Private Equity Investor | |
THE MEDICINES COMPANY | Pharmaceuticals: Major | Consultant / Advisor | |
Duke University
Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Undergraduate Degree | |
MINERVA SURGICAL, INC. | Medical Specialties | Director/Board Member | |
Ocutherix, Inc.
Ocutherix, Inc. Medical SpecialtiesHealth Technology Ocutherix, Inc. operates as a medical device incubator which focuses on novel medical technologies. The firm serves the ophthalmology, cardiology, mobile health, orthopedics, neurology, pulmonology and metabolic clinical solutions. The company was founded by Robert E. Atkinson in 2005 and is headquartered in Stillwater, MN. | Medical Specialties | Director/Board Member | |
Rezo Therapeutics, Inc.
Rezo Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Rezo Therapeutics, Inc. is a drug discovery company based in San Francisco, CA. The company's mission is to revolutionize traditional drug development by integrating proteomics, genetics, structural biology, chemistry, artificial intelligence, and machine learning to create maps of molecular disease networks. Rezo's initial focus is on oncology, but they plan to explore additional therapeutic areas through collaborations and partnerships. The company was founded by Natalia Jura, Kevan Shokat, Nevan Krogan, Sourav Bandyopadhyay, Norbert W. Bischofberger, and George A. Scangos, with Nevan Krogan serving as CEO since incorporation. | Miscellaneous Commercial Services | Director/Board Member | |
Rotation Medical, Inc.
Rotation Medical, Inc. Medical SpecialtiesHealth Technology Rotation Medical, Inc. develops treatment of rotator cuff disease. It includes a bioinductive implant and a set of disposable arthroscopic instruments that has been shown to heal tendons by inducing the growth of new tendon-like tissue. The company was founded by Thomas R. Hektner in 2009 and is headquartered in Plymouth, MN. | Medical Specialties | Director/Board Member | |
ANAPTYSBIO, INC. | Biotechnology | Director/Board Member | |
Allievex Corp.
Allievex Corp. Pharmaceuticals: OtherHealth Technology Allievex Corp. operates as a biotechnology company. It develops therapies for the treatment of rare pediatric neurodegenerative diseases. The company was founded by Thomas P. Mathers and Eric H. Zanelli and is headquartered in Marblehead, MA. | Pharmaceuticals: Other | Director/Board Member | |
Adaptimmune Ltd.
Adaptimmune Ltd. Medical/Nursing ServicesHealth Services Adaptimmune Ltd. develops T cell therapies to treat cancer, human immunodeficiency virus, and infectious diseases. It utilizes the T cell to target and destroy cancerous and infected cells by using affinity T cell receptor proteins as a means of strengthening patient T cell responses. The company was founded by Bent K. Jakobsen, James Julian Noble and Helena Katrina Tayton-Martin in 2008 and is headquartered in Oxford, the United Kingdom. | Medical/Nursing Services | Director/Board Member | |
The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin | |
Ivantis, Inc.
Ivantis, Inc. Medical SpecialtiesHealth Technology Ivantis, Inc. develops technology to treat ophthalmic diseases. The firm develops solutions for glaucoma and offers an intracanalicular scaffold or implantable device that relieves high intraocular pressures in patients. It provides its solutions for use in clinical trials to ophthalmology specialists. Ivantis was founded in 2007 and is headquartered in Irvine, CA. | Medical Specialties | Director/Board Member | |
ADAPTIMMUNE THERAPEUTICS PLC | Biotechnology | Director/Board Member |
Statistiche
Distribuzione geografica
Stati Uniti | 39 |
Canada | 6 |
Regno Unito | 4 |
Australia | 3 |
Germania | 2 |
Settori
Health Technology | 24 |
Commercial Services | 11 |
Finance | 6 |
Consumer Services | 6 |
Technology Services | 3 |
Posizioni
Director/Board Member | 134 |
Independent Dir/Board Member | 33 |
Corporate Officer/Principal | 28 |
Private Equity Investor | 14 |
Undergraduate Degree | 13 |
Contatti più connessi
Insiders | |
---|---|
Ali Behbahani | 35 |
Lisa Suennen | 30 |
Brad H. Vale | 28 |
Peter Bisgaard | 28 |
Tiba Aynechi | 24 |
Bill Hunter | 22 |
Karimah Es Sabar | 16 |
Shawn McCormick | 16 |
Khaled El-Emam | 9 |
Richard Carter | 8 |
Amanda Gillon | 8 |
David Caraway | 6 |
Michael W. Hall | 6 |
Neeraj Teotia | 5 |
Jim Karkanias | 2 |
- Borsa valori
- Insiders
- Balakrishnan Shankar
- Connessioni Società